[Comparison of the estrogen and progesterone receptor content of primary breast cancers without skeletal or visceral metastasis with tumor marker MCA, CEA and CA 15-3 serum concentration at the time of surgery].
Seifert
M
M
I. Univers.-Frauenklinik Wien.
Wierrani
F
F
Kubista
E
E
Spona
J
J
D000951:Antigens, Neoplasm / Q000097:blood*; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D001859:Bone Neoplasms / Q000097:blood / Q000473:pathology / Q000556:secondary*; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000097:blood* / Q000473:pathology / Q000601:surgery*; D002272:Carcinoembryonic Antigen / Q000097:blood*; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D009376:Neoplasms, Hormone-Dependent / Q000097:blood* / Q000473:pathology / Q000601:surgery*; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C057387:mucinous carcinoma-associated antigen
Vergleich von Ostrogen- und Progesteronrezeptorengehalt von primären Mammakarzinomen ohne skelettaler oder viszeraler Metastasierung mit der Serumkonzentration der Tumormarker MCA, CEA und CA 15-3 zum Zeitpunkt der Operation.